Nesli Basgoz Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nesli Basgoz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nesli Basgoz. Nesli Basgoz is Director in Forest Laboratories, LLC ($FRX) and Director in Allergan plc ($AGN).
Latest Insider Trading Transactions of Nesli Basgoz
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 70.79 | 2,619 | 185,399 | 0 | |
| May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 73.14 | 3,691 | 269,960 | 0 | |
| May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | D | 90.22 | 2,790 | 251,714 | 0 | |
| May 12 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | D | 0.00 | 6,889 | 0 | 0 | 6.9 K to 0 (-100.00 %) |
| May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 6,889 | 7.9 K to 6.9 K (-12.58 %) |
| May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 280 | 0 | 7,880 | 8.2 K to 7.9 K (-3.43 %) |
| May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 189.74 | 991 | 188,032 | 6,889 | 7.9 K to 6.9 K (-12.58 %) |
| May 04 2020 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 280 | 0 | 7,880 | 8.2 K to 7.9 K (-3.43 %) |
| Dec 09 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 47 | 0 | 8,160 | 8.2 K to 8.2 K (-0.57 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 145.33 | 2,064 | 299,961 | 8,207 | 6.1 K to 8.2 K (+33.60 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 6,143 | 7.1 K to 6.1 K (-13.43 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 145.33 | 2,064 | 299,961 | 8,207 | 6.1 K to 8.2 K (+33.60 %) |
| May 02 2019 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 147.00 | 953 | 140,091 | 6,143 | 7.1 K to 6.1 K (-13.43 %) |
| Sep 04 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 263 | 0 | 7,096 | 7.4 K to 7.1 K (-3.57 %) |
| Sep 04 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 190.05 | 1,055 | 200,503 | 7,359 | 8.4 K to 7.4 K (-12.54 %) |
| Aug 14 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 81.16 | 1,889 | 153,311 | 0 | |
| Aug 14 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 184.00 | 834 | 153,456 | 8,414 | 9.2 K to 8.4 K (-9.02 %) |
| Aug 14 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 81.16 | 1,889 | 153,311 | 9,248 | 7.4 K to 9.2 K (+25.67 %) |
| May 04 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 151.07 | 1,985 | 299,874 | 7,359 | 5.4 K to 7.4 K (+36.94 %) |
| May 03 2018 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 152.94 | 588 | 89,929 | 5,374 | 6 K to 5.4 K (-9.86 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 15 | 0 | 5,962 | 6 K to 6 K (-0.25 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 6 | 0 | 5,977 | 6 K to 6 K (-0.10 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 15 | 0 | 5,983 | 6 K to 6 K (-0.25 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 45 | 0 | 5,998 | 6 K to 6 K (-0.74 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | L | 235.96 | 7 | 1,652 | 6,043 | 6 K to 6 K (+0.12 %) |
| Dec 26 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | L | 242.21 | 6 | 1,453 | 5,481 | 5.5 K to 5.5 K (+0.11 %) |
| May 22 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 84.44 | 1,889 | 159,507 | 0 | |
| May 22 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 220.45 | 1,889 | 416,430 | 6,030 | 7.9 K to 6 K (-23.85 %) |
| May 22 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 84.44 | 1,889 | 159,507 | 7,919 | 6 K to 7.9 K (+31.33 %) |
| May 05 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 245.25 | 1,223 | 299,941 | 6,030 | 4.8 K to 6 K (+25.44 %) |
| May 05 2017 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 243.76 | 668 | 162,832 | 4,807 | 5.5 K to 4.8 K (-12.20 %) |
| Dec 27 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 40 | 0 | 5,475 | 5.5 K to 5.5 K (-0.73 %) |
| Dec 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 188.72 | 500 | 94,360 | 5,515 | 6 K to 5.5 K (-8.31 %) |
| Aug 17 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 254.05 | 100 | 25,405 | 6,015 | 6.1 K to 6 K (-1.64 %) |
| Aug 17 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 254.05 | 100 | 25,405 | 6,015 | 6.1 K to 6 K (-1.64 %) |
| Aug 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 97.62 | 1,889 | 184,404 | 12,878 | |
| Aug 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 248.31 | 201 | 49,910 | 6,115 | 5.9 K to 6.1 K (+3.40 %) |
| Aug 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 253.02 | 758 | 191,789 | 5,914 | 6.7 K to 5.9 K (-11.36 %) |
| Aug 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 97.62 | 1,889 | 184,404 | 6,672 | 4.8 K to 6.7 K (+39.49 %) |
| May 12 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 82.53 | 459 | 37,881 | 459 | |
| May 12 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 225.10 | 459 | 103,321 | 4,783 | 5.2 K to 4.8 K (-8.76 %) |
| May 12 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 82.53 | 459 | 37,881 | 5,242 | 4.8 K to 5.2 K (+9.60 %) |
| May 09 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 210.34 | 1,188 | 249,884 | 4,783 | 3.6 K to 4.8 K (+33.05 %) |
| May 06 2016 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 214.62 | 397 | 85,204 | 3,595 | 4 K to 3.6 K (-9.94 %) |
| Dec 17 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 62 | 0 | 3,992 | 4.1 K to 4 K (-1.53 %) |
| Dec 17 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Gift | G | 0.00 | 8 | 0 | 4,054 | 4.1 K to 4.1 K (-0.20 %) |
| Dec 09 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 82.53 | 2,300 | 189,819 | 459 | |
| Dec 09 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 312.96 | 2,300 | 719,808 | 4,062 | 6.4 K to 4.1 K (-36.15 %) |
| Dec 09 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 82.53 | 2,300 | 189,819 | 6,362 | 4.1 K to 6.4 K (+56.62 %) |
| Aug 25 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 298.57 | 124 | 37,023 | 4,062 | 4.2 K to 4.1 K (-2.96 %) |
| Aug 18 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 314.50 | 100 | 31,450 | 4,186 | 4.3 K to 4.2 K (-2.33 %) |
| Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Option Exercise | M | 82.53 | 2,200 | 181,566 | 2,759 | |
| Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Sell | S | 297.89 | 2,200 | 655,358 | 4,286 | 6.5 K to 4.3 K (-33.92 %) |
| Jun 10 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Buy | M | 82.53 | 2,200 | 181,566 | 6,486 | 4.3 K to 6.5 K (+51.33 %) |
| Jun 08 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Grant | A | 302.30 | 826 | 249,700 | 4,286 | 3.5 K to 4.3 K (+23.87 %) |
| Jun 08 2015 | AGN | Allergan plc | Basgoz Nesli | Director | Payment of Exercise | F | 303.38 | 334 | 101,329 | 3,460 | 3.8 K to 3.5 K (-8.80 %) |
| May 22 2006 | FRX | Forest Laboratorie ... | Basgoz Nesli | Director | Option Exercise | A | 38.98 | 14,000 | 545,650 | 14,000 |
Page: 1